| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Restricted cash | 46 | 46 | ||
| Right of use asset | 942 | 1,077 | ||
| In-process research and development | 19,614 | 19,624 | ||
| Deposits and other assets | 82 | 82 | ||
| Total assets | 30,836 | 35,830 | ||
| Total stockholders' equity | 6,738 | 10,623 | ||
| Total liabilities and stockholders' equity | 30,836 | 35,830 | ||
Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc. (TOVX)